Logo for OncoCyte Corporation

OncoCyte Investor Relations Material

Latest events

Logo for OncoCyte Corporation

Q3 2024

OncoCyte
Logo for OncoCyte

Q3 2024

12 Nov, 2024
Logo for OncoCyte

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from OncoCyte Corporation

Access all reports
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. Its tests apply genetic analysis technology to advance early detection of cancer. The company's lead product candidates are Circulating Tumor Cell (CTC), a blood test to detect lung cancer; and DetermaIO, a bioinformatic analysis software that provides interpretative information on the outputs from various types of assays, including CTC. It is also developing DetermaVu, a cell free DNA blood test for detecting various types of lung cancer; DetermaSolver, a proprietary technology.